National Healthcare Stock Alpha and Beta Analysis
| NHC Stock | USD 130.41 6.68 4.87% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as National HealthCare. It also helps investors analyze the systematic and unsystematic risks associated with investing in National HealthCare over a specified time horizon. Remember, high National HealthCare's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to National HealthCare's market risk premium analysis include:
Beta 0.6 | Alpha 0.0828 | Risk 1.52 | Sharpe Ratio 0.12 | Expected Return 0.17 |
National HealthCare Quarterly Cash And Equivalents |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out National HealthCare Backtesting, National HealthCare Valuation, National HealthCare Correlation, National HealthCare Hype Analysis, National HealthCare Volatility, National HealthCare History and analyze National HealthCare Performance. National HealthCare Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. National HealthCare market risk premium is the additional return an investor will receive from holding National HealthCare long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in National HealthCare. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate National HealthCare's performance over market.| α | 0.08 | β | 0.60 |
National HealthCare expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of National HealthCare's Buy-and-hold return. Our buy-and-hold chart shows how National HealthCare performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.National HealthCare Market Price Analysis
Market price analysis indicators help investors to evaluate how National HealthCare stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading National HealthCare shares will generate the highest return on investment. By understating and applying National HealthCare stock market price indicators, traders can identify National HealthCare position entry and exit signals to maximize returns.
National HealthCare Return and Market Media
The median price of National HealthCare for the period between Sun, Oct 5, 2025 and Sat, Jan 3, 2026 is 126.77 with a coefficient of variation of 6.02. The daily time series for the period is distributed with a sample standard deviation of 7.73, arithmetic mean of 128.5, and mean deviation of 7.01. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Morgans says accumulate these ASX 300 shares | 10/07/2025 |
2 | QAN and SOL shares 2 ASX shares to watch | 10/29/2025 |
| National HealthCare dividend paid on 31st of October 2025 | 10/31/2025 |
3 | Heres Why Some Shareholders May Not Be Too Generous With New Hope Corporation Limiteds CEO Compensation This Year | 11/13/2025 |
4 | National HealthCare Corp stock hits 52-week high at 133.44 USD - Investing.com India | 11/24/2025 |
5 | Director Emil Hassan Sells 7,500 Shares of National Healthcare C - GuruFocus | 11/26/2025 |
6 | Disposition of 3734 shares by B Flatt of National HealthCare at 63.96 subject to Rule 16b-3 | 12/01/2025 |
7 | National HealthCare Stock Crosses Above Two Hundred Day Moving Average - Whats Next - MarketBeat | 12/02/2025 |
8 | 3 great ASX shares Im buying to become a millionaire | 12/12/2025 |
9 | Disposition of tradable shares by R Ussery of National HealthCare subject to Rule 16b-3 | 12/17/2025 |
10 | National HealthCare VP Sells 342,136.68 in Stock - MarketBeat | 12/18/2025 |
11 | Disposition of 450 shares by Stephen Flatt of National HealthCare subject to Rule 16b-3 | 12/29/2025 |
About National HealthCare Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including National or other stocks. Alpha measures the amount that position in National HealthCare has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2024 | 2025 | 2026 (projected) | Dividend Yield | 0.0223 | 0.0257 | 0.0244 | Price To Sales Ratio | 1.28 | 1.15 | 0.64 |
National HealthCare Upcoming Company Events
As portrayed in its financial statements, the presentation of National HealthCare's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, National HealthCare's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of National HealthCare's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of National HealthCare. Please utilize our Beneish M Score to check the likelihood of National HealthCare's management manipulating its earnings.
| 16th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with National HealthCare
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out National HealthCare Backtesting, National HealthCare Valuation, National HealthCare Correlation, National HealthCare Hype Analysis, National HealthCare Volatility, National HealthCare History and analyze National HealthCare Performance. For information on how to trade National Stock refer to our How to Trade National Stock guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
National HealthCare technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.